Three-year efficacy and safety of tenofovir disoproxil fumarate in nucleos(t)ide analog-naive and -experienced chronic hepatitis B patients

Trial Profile

Three-year efficacy and safety of tenofovir disoproxil fumarate in nucleos(t)ide analog-naive and -experienced chronic hepatitis B patients

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Feb 2016

At a glance

  • Drugs Tenofovir (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Feb 2016 New trial record
    • 12 Jan 2016 Results published in the Journal of Gastroenterology and Hepatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top